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Anti-diabetic effects of an alcoholic extract of
Juglans regia in an animal model
Jamshid MOHAMMADI1, Khalil SAADIPOUR1, Hamdollah DELAVIZ2, Bahram MOHAMMADI3

Aim: Many traditional treatments have been recommended in the alternative system of medicine for treatment of
diabetes mellitus. Juglans regia is one of the medicinal plants used in traditional Iranian medicine as a treatment for
diabetes, but little scientific documentation supports its antidiabetic action. The purpose of this study was to investigate
antidiabetic effect of J. regia leaves in type 1 diabetes induced animal model.
Materials and methods: Four groups of animals were selected. Group I animals were fed a normal diet. Animals of
groups II, III, and IV received streptozotocin. Animals of groups III and IV were treated with J. regia leaf extract 200 and
400 mg/kg body weight for 28 days. The various parameters studied included body weight, blood glucose, triglycerides,
cholesterols, LDL, VLDL, HDL, insulin, and glycated hemoglobin in all groups.
Results: Treatment with the J. regia extracts resulted in a significant decrease in blood glucose, glycosylated hemoglobin,
LDL, triglyceride, and total cholesterol, and a significant increase in insulin and HDL level.
Conclusion: The plant extract is capable of ameliorating hyperglycemia in streptozotocin-induced diabetic rats and is a
potential source for active agent(s) for diabetes mellitus. It is concluded that J. regia leaf extract can be potentially used
to control type 1 diabetes.
Key words: Juglans regia, streptozotocin, insulin, diabetes mellitus, glucose, triglyceride, cholesterol

Introduction
Diabetes mellitus is a group of metabolic alterations characterized by hyperglycemia resulting
from defects in insulin secretion, action, or both. It has already been established that chronic
hyperglycemia resulting from diabetes is associated with long term damage, dysfunction, and
eventually the failure of organs, especially the eyes, kidneys, nerves, heart and blood vessels (1).
The number of people suffering from the disease worldwide is increasing at an alarming rate with
a projected 366 million people likely to be diabetic by the year 2030 compared to an estimated
191 million sufferers in 2000 (2). Herbal drugs are gaining popularity in the treatment of diabetic
mellitus (3). The major advantages of herbal medications seem to be their efficacy, low incidence
of side effects, and low cost. A review of the literature reveals that 15%-20% of diabetic patients
are suffering from insulin-dependent diabetes mellitus (IDDM), also known as type-I diabetes
(4). This condition, IDDM, is noted both in adults and children (4,5). It is characterized by an
elevation of both fasting and postprandial blood sugar levels. Chronic hyperglycemia during
diabetes causes glycation of body proteins that in turn leads to secondary complications affecting
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the eyes, kidneys, nerves, and arteries (6). These may
be delayed, lessened, or prevented by maintaining
blood glucose levels that are close to normal.
In modern medicine, no satisfactory effective
therapy is yet available to cure diabetes mellitus.
Insulin therapy is used for the management of
diabetes mellitus, but there are several drawbacks
such as insulin resistance, anorexia nervosa, brain
atrophy, and fatty liver after chronic treatment
(7,8). Besides the use of insulin for the treatment
of insulin dependent diabetes mellitus (IDDM),
other approaches for the control of hyperglycemia
include the use of amylin analogues, which regulate
gastric emptying, and intestinal alpha-glucosidases
inhibitors such as acarbose, miglitol, and voglibose,
which delay postprandial hyperglycemia.
Recently, there has been increasing interest in
the use of medicinal plants. The use of medicinal
plants in modern medicine suffers from the fact that
though hundreds of plants are used throughout the
world to prevent or cure diseases, scientific evidence
of the efficacy of these plants is lacking in most cases.
Today, however, it is necessary to provide scientific
proof in order to justify the use of a plant or its active
components (9). At this time, approximately 1200
types of therapeutic plants are thought to reduce
glucose level in diabetes (10). The search for suitable
anti-hyperglycemic agents has focused on plants
used in traditional medicine because of indications
that natural products may provide better treatment
than the drugs that are currently being used (11).
The preliminary phytochemical studies of an
ethanol extract of Juglans regia showed the presence
of alkaloids, flavonoids, and saponins (12). Because
any of these phytoconstituents may be responsible
for the extract’s pharmacological activity, more
detailed studies of the phytoconstituents should be
undertaken in order to confirm the exact mode of the
pharmacological action. The purpose of this study
was merely to raise awareness about the anti-diabetic
activity of the alcohol extract Juglans regia (J. regia).
Materials and methods
Plant material and extraction procedure
The J. regia leaves were collected from a garden
in the east of the city of Yasouj. The fourth and fifth
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leaves from the apex of healthy plants were plucked,
washed thoroughly under running tap water, shade
dried for 5 days, and ground to a fine powder in an
electric mixer. The powdered plant material (700 g)
was twice subjected to extraction with 90% ethanol
at room temperature, with each extraction lasting 24
h. The extract was filtered using Whatman No 1 filter
paper. The filtrate was evaporated using a Soxhlet
evaporator until dry and 80.4 g of the extracted
powder were obtained. The dried powder was diluted
with distilled water to concentrations of 200 and
400 mg/kg. Our experiments involved Wistar rats
which were procured from the animal house of the
department of physiology. The Institutional Animal
Ethics Committee (Yasouj University of Medical
Sciences’ local committee on ethics) approved
the experimental protocols in the present study
(88.11.17.12.). The animals were maintained under
standard conditions, in temperatures of 20 ± 5 °C with
a regular 12 h light/dark cycle. They were allowed
free access to standard laboratory food and water
ad libitum throughout the experiment. At 6 weeks
of age, the animals, all of which had a body weight
ranging between 160 and 220 g, were distributed into
4 groups, irrespective of sex. Each group consisted
of 8 animals and the groups were divided as follows:
a control group (Group I), a diabetic group (Group
II), a diabetic group treated with daily dosages of 200
mg/kg of the extract taken from the J. regia leaves
(Group III), and a diabetic group treated with daily
dosages of 400 mg/kg of the same extract (Group IV).
Experimental design
Animals in Groups II, III, and IV were rendered
diabetic by single intraperitoneal (IP) injection of
streptozotocin (STZ - 55 mg/kg) (Sigma, St. Louis,
MO, USA) freshly prepared in 0.1 mol of citrate
buffer (pH 4.5). Group I animals were injected
with only the buffer. Blood was drawn from the
tails of conscious rats 72 h after they were given the
injections and glucose was estimated by glucometer.
Diabetes was identified by glucose results; rats with a
glucose level over 300 mg/dL were considered to be
diabetic and were used in the experiment (13). Blood
glucose was similarly monitored every week until
autopsy. After 10 days of STZ injections, animals in
Group III began receiving daily dosages of 200 mg/
kg while Group IV received 400 mg/kg daily of the J.
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regia leaf extract. The animals were given the extract
orally by an intragastric tube once daily for 28 days.
The stock solution was prepared for multiple groups,
such that 1 mL of extraction was administered per
day for each animal. Body weight was recorded
weekly for each group. After 28 days of treatment,
rats were fasted overnight and autopsied under light
ether anesthesia. Blood was collected from the heart,
transferred immediately into centrifuge tubes, and
allowed to clot on order to obtain a serum.
Plasma glucose was estimated by Trinder’s method
using a GOD/POD kit (14). Total cholesterol was
estimated by using Parekh and Jung’s method (15).
Glycosylated hemoglobin was determined according
to the ion-exchange resin method (16). Triglycerides
were measured with the enzyme-colorimetric method
(17). HDL-cholesterol was assayed by the method
of Burstein et al. (18). LDL-cholesterol and VLDLcholesterol were measured by using the formula of
Friendwald et al. (19).

Table 1. Effects of Juglans regia leaves extract on body weight
levels (g).
Group

Initial

Final

Control
I

175.4 ± 2.76b

208.4 ± 0.81d

Diabetic
II

172 ± 4.15b

143.2 ± 5.21a

STZ+200
III

175.5 ± 6.91b

180.1 ± 4.32b

STZ+400
IV

168.4 ± 3.49b

185 ± 6.44b,c

The values are mean ± SE for 8 rats in each group. Means with
different superscript (a, b, c, d) within a column are significantly
different from each other at P < 0.05 as determined by Duncan's
multiple range test.
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Results were analyzed statistically using an
analysis of variance (ANOVA) and represented
as mean ± standard error (SE). Wherever the
variance value was found to be significant (5%),
Duncan’s multiple range test (DMRT) was applied.
Results
The animals’ final body weight showed a significant
increase from initial body weight in Groups I and
IV. There was a significant decrease in body weight
compared to initial body weight in the diabetic group
(Table 1). The failure of the diabetic rats to gain
weight during the 4 week period corresponded with
the hyperglycemia seen during this period. Animals
in Group III and IV demonstrated greater weight
gain than the diabetic group (Group II), but less than
that of the control group (Group I).
Figure 1 shows changes in the rats’ fasting blood
glucose levels over the course of 28 days. Control rats
did not show any significant variation in blood glucose
throughout the experimental period. Administration
of STZ (55 mg/kg) led to over fourfold elevation of
blood glucose levels which remained consistent over
the 28-day period. At a potency of 200 mg/kg, the J.
regia extract reduced the hyperglycemia significantly

mg/dL

Statistical analysis

400
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0
0
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Figure 1. The effects of J. regia leaves extract on blood glucose
levels are shown for a control group (I), a diabetic
group (II), a diabetic group treated with a daily dosage
of 200 mg/kg (III) and a diabetic group treated with a
daily dosage of 400 mg/kg (IV). Each point represents
mean ± SE for 8 rats.

compared to diabetic group but failed to restore the
level to that of control group, whereas the treatment
using 400 mg/kg almost reached the same level as the
control group (P < 0.05).
Table 2 shows changes in fasting HbA1c levels
after 28 days. The ethanol extract of J. regia had a
significant effect on lowering HbA1c levels. Both
the 200 mg/kg and 400 mg/kg treatments caused a
decrease in glycolated hemoglobin and the extract
with 400 mg/kg of J. regia brought glycolated
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Table 2. The effects of Juglans regia leaves extract on glycosylated hemoglobin,triglyceride, cholesterol, LDL, VLDL, and HDL levels.

Group

Control

Diabetic

STZ+200

STZ+400

F value

Parameters

I

II

III

IV

df(3,20)

6.52 ± 0.12a

12.33 ± 0.29c

9.20 ± 1.11b

6.41 ± 1.05a

64.1 ± 4.72a,b

85.2 ± 3.58c

69.18 ± 3.52b

57.1 ± 2.4a

74.5 ± 3.66b

84.1 ± 4.61c

69.7 ± 3.77b

56.9 ± 5.19a

33.22 ± 3.1b

41.5 ± 2.6c

22.95 ± 3.6a,b

11.74 ± 0.72a

16.32 ± 1.45c

13.54 ± 1.96b

11.42 ± 0.98a

31.14 ± 1.49a,b

27.2 ± 0.55a

29.76 ± 1.33a,b

31.52 ± 2.71b

Glycosylated
Hemoglobin

Sig
12.43

(%Hb)
Triglycerides
mg/dL
Cholesterol
mg/dL
LDL
mg/dL
VLDL
mg/dL
HDL
mg/dL

Sig
11.78
Sig
15.88
Sig

19.1 ± 33a

15.2

7.82
Sig
13.39
NS
4.87

The values are mean ± SE for 8 rats in each group. Means with different superscript (a, b, c, d) within a column are significantly different
from each other at P < 0.05 as determined by Duncan's multiple range test.

hemoglobin levels close to those of the control group
(P < 0.05).

Finally, Table 2 also shows changes in fasting total
cholesterol, LDL, VLDL, and HDL levels after 28 days.
In the diabetic group (Group II), total cholesterol,
LDL, and VLDL levels were elevated after 28 days
while the treatment brought Group IV’s levels into
line with the control group’s levels. HDL levels did
not change significantly in any of the groups studied
(P < 0.05).
Figure 2 provides information about insulin levels
in the experimental animals. Group I, the control
group, did not show any significant variations in
insulin levels. There was a significant decrease in
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In addition, Table 2 shows changes in fasting blood
triglyceride levels after 28 days. Triglycerides were
elevated significantly in the diabetic group (Group
II) and brought to the same level as the control
group in Group IV (P < 0.05). The ethanol extract
of J. regia had a significant effect on lowering blood
triglycerides.
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Figure 2. The effect of J. regia leaves extract on insulin levels (ng/
dL) are shown for a control group (I), a diabetic group
(II), a diabetic group treated with a daily dosage of 200
mg/kg (III) and a diabetic group treated with a daily
dosage of 400 mg/kg (IV). The vertical bars are showing
mean values of insulin levels (ng/dL). Lines above the
bars indicate standard error (SE). The asterisk symbol
(*) indicates that P < 0.05 when comparing Group II
to Group I . The yen symbol (¥) indicates that P < 0.05
when comparing Group IV to Group II.
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insulin levels in the diabetic group (Group II).
However, the level of insulin was enhanced in Groups
III and IV after treatment with the J. regia leaf extract.
The insulin levels of Group IV animals almost reached
that of those in the control group.
Discussion
The present observation of the hypoglycemic
effect of J. regia leaves supports a number of other
observations regarding the efficacy of plant extracts.
Lemus et al. (20) reported on the hypoglycemic activity
of dried leaves of the Bauhinia ulrifolius, Galega
officinalis, Morus alba, and Rubus ulnifolius plants.
They conducted short term experiments. Sachdewa
and Khemani (21) reported on the hypoglycemic
activity of an ethanol extract of the flower Hibiscus
rosa sinensis on diabetes-induced rats. Andallu and
Varadacharyulu (22) in their studies reported that
fasting blood glucose levels were reduced in diabetic
groups treated with mulberry. Mohammadi and Naik
(23) reported that administering an extract from the
Morus alba leaf for five weeks significantly improved
hypertriglyceridemia and hypercholesterolemia.
Komeili and Bagheri (24) in their studies reported
that fasting blood glucose levels in diabetic groups
treated with a J. regia extract were only reduced by
17% whereas in the present investigation both 200
and 400 mg/kg treatments restored the blood glucose
level to that of the control group (Figure 1).
Throughout the circulatory life of red blood cells,
glycohemoglobin is formed continuously by the
addition of glucose to the N-terminal of a hemoglobin
beta chain. This process, which is non-enzymatic,
reflects the average exposure of hemoglobin to
glucose over an extended period. Several investigators
have suggested that glycosylated hemoglobin serves
as an indicator of metabolic control of diabetes since
glycohemoglobin levels approach normal values
for diabetics in metabolic control (23,25,26). In the
present investigation, glycosylated hemoglobin was
elevated nearly 200% in the diabetic group (Group
II). In Group IV, levels of glycosylated hemoglobin
decreased to values that were close to those of the
control group (Group I).
The most common lipid abnormalities in diabetes
are hypertriglyceridemia and hypercholesterolemia.

Increased levels of triglycerides are a risk factor
for atherosclerotic coronary disease. Repeated
administration of the J. regia leaf extract for 28 days
significantly improved hypertriglyceridemia and
hypercholesterolemia, bringing their levels in Group
IV to those of the control group (Table 2). LDL and
VLDL carry cholesterol to peripheral tissues where
it can be deposited. Therefore, high levels of LDL
and VLDL are atherogenic whereas HDL transports
cholesterol from peripheral tissue to the liver,where
it can be processed for excretion. Hence, HDL has a
protective effect. In the present investigation, HDL
levels did not change significantly in any of the
groups of rats studied (Table 2). Tavakkoli et al. (27)
have shown that replacing some fatty acids in the
diet with walnuts for four weeks caused a decrease
in total cholesterol and LDL cholesterol values
among menopausal women , whereas in the present
investigation all these parameters were reduced
significantly when compared to the diabetic rats and
ultimately reached the level of the control group.
The improvement in glycemic control followed by
a decrease in VLDL production after J. regia treatment
could be attributed to J. regia therapy in diabetic rats.
Laakso et al. (28) and Laakso (29) showed improved
glycemic control followed by a decrease in VLDL
production in diabetic patients after being treated
with oral agents. The overall effect of J. regia on VLDL
metabolism could be due to a 2-fold course of action:
reduction in VLDL production and enhancement of
VLDL removal. Earlier studies of Laakso (29) and
Taskinen (30) encountered a higher concentration
of LDL cholesterol and lower concentration of HDL
cholesterol in diabetic patients. Hypocholesteromic
drugs decrease LDL cholesterol, presumably by
stimulating receptor-mediated removal of LDL. This
seems a likely explanation for J. regia treatment,
which shows a decrease in LDL and no alteration
in HDL-cholesterol control. The single dose STZinduced diabetic rat is one of the animal models of
human insulin dependent diabetes mellitus (IDDM)
or type I diabetes mellitus. In this model, diabetes
arises from irreversible destruction of the β-cells of
the pancreas, causing degranulation or reduction of
insulin secretion. In this type I model of diabetes,
insulin is markedly depleted, but not absent (31).
Although insulin has become one of the most
important therapeutic agents known to medicine,
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there is a continuing effort to find insulin substitutes,
secretagogues, or sensitizers from synthetic or plant
sources for the treatment of diabetes. Hypoglycemic
effects have been reported for some plants that
contain flavonoids (31), as J. regia does. The present
study demonstrated that the alcoholic extract of J.
regia has marked hypoglycemic property when given
for 28 days to STZ-diabetic rats. Such an effect might
be accounted for, in part, by a decrease in the rate of
intestinal glucose absorption, as has been noted, for
example, when plant fiber is given orally with glucose
(32). Hence, it may be presumed that the glucoselowering effect of the plant extract was achieved
by an extraintestinal action. Plasma insulin levels
in Group IV were significantly higher on Day 28
compared to the untreated diabetic group (Group II).
The elevation in plasma insulin levels in STZ diabetic
rats treated with the alcoholic J. regia extract could be
due to substances present in the plant extract which

stimulate insulin secretion or which protect the
intact functional β-cells from further deterioration
so that they remain active and continue to produce
insulin. Protection of the β-cells could also be, at least
in part, a result of the reduction in blood glucose,
thereby eliminating gluco-toxicity to the β-cells.
This possibility is strengthened by the observation of
insulin concentration.
In conclusion, our present investigation shows
the therapeutic efficacy of J. regia leaves on diabetesinduced animal model at a treatment of 400 mg/kg
per day.
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